Detection of cancer stem cell markers in sarcomas

Klinicka Onkologie

Volumn 25, Issue SUPPL.2, 2012, Pages

  Veselska, Renata ^a,b   Skoda, J ^a,b   Neradil, J ^a,c  

^a MASARYK UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^c MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

Author keywords

ABC transporters; Aldehyde dehydrogenase; Cancer stem cells; CD133; Nestin; Osteosarcoma; Rhabdomyosarcoma; Tumourigenicity

Indexed keywords

ABC TRANSPORTER; ALDEHYDE DEHYDROGENASE; ANTINEOPLASTIC AGENT; CD133 ANTIGEN; NESTIN;

CANCER DIAGNOSIS; CANCER GROWTH; CANCER RESISTANCE; CANCER STEM CELL; CARCINOGENICITY; DISEASE MARKER; HUMAN; METASTASIS; PHENOTYPE; PROTEIN EXPRESSION; REVIEW; SARCOMA;

ALDEHYDE DEHYDROGENASE; ANTIGENS, CD; ATP-BINDING CASSETTE TRANSPORTERS; GLYCOPROTEINS; HUMANS; INTERMEDIATE FILAMENT PROTEINS; NEOPLASTIC STEM CELLS; NERVE TISSUE PROTEINS; PEPTIDES; SARCOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 84872484000     PISSN: 0862495X     EISSN: 18025307     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Ratajczak MZ. Cancer stem cells - normal stem cells "Jedi" that went over to the "dark side". Folia Histochem Cytobiol 2005; 43(4): 175-181. (Pubitemid 41582134)
2. Fábián A, Barok M, Vereb G et al. Die hard: are cancer stem cells the Bruce Willises of tumor biology? Cytometry A. 2009; 75(1): 67-74.
3. Garvalov BK, Acker T. Cancer stem cells: a new framework for the design of tumor therapies. J Mol Med (Berl) 2011; 89(2): 95-107.
4. Scatena R, Bottoni P, Pontoglio A et al. Cancer stem cells: An innovative therapeutic approach. In: Scatena R, Mordente A, Giardina B (eds). Advances in Cancer Stem Cell Biology. Springer 2012: 239-266.
5. Siclari VA, Qin L. Targeting the osteosarcoma cancer stem cell. J Orthop Surg Res 2010; 5(1): 78-87.
6. Grosse-Gehling P, Fargeas CA, Dittfeld C et al. CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges. J Pathol. DOI: 10.1002/path.4086. Epub ahead of print 2012.
7. Olempska M, Eisenach PA, Ammerpohl O et al. Detection of tumor stem cell markers in pancreatic carcinoma cell lines. Hepatobiliary Pancreat Dis Int 2007; 6(1): 92-97. (Pubitemid 46243168)
8. Veselska R, Hermanova M, Loja T et al. Nestin expression in osteosarcomas and derivation of nestin/CD133 positive osteosarcoma cell. BMC Cancer 2008; 8: 300.
9. Tirino V, Desiderio V, d'Aquino R et al. Detection and characterization of CD133+ cancer stem cells in human solid tumours. PLoS One 2008; 3: e3469.
10. Tirino V, Desiderio V, Paino F et al. Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo. FASEB J 2011; 25(6): 2022-2030.
11. Di Fiore R, Santulli A, Ferrante RD et al. Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment. J Cell Physiol 2009; 219(2): 301-313.
12. Saini V, Hose CD, Monks A et al. Identification of CBX3 and ABCA5 as putative biomarkers for tumor stem cells in osteosarcoma. PLoS One 2012; 7: e41401.
13. He A, Qi W, Huang Y et al. CD133 expression predicts lung metastasis and poor prognosis in osteosarcoma patients: A clinical and experimental study. Exp Therap Med 2012; 4(3): 435-441.
14. Terry J, Nielsen T. Expression of CD133 in synovial sarcoma. Appl Immunohistochem Mol Morphol 2010; 18(2): 159-165.
15. Sana J, Zambo I, Skoda J et al. CD133 expression and identification of CD133/nestin positive cells in rhabdomyosarcomas and rhabdomyosarcoma cell lines. Anal Cell Pathol (Amst) 2011; 34(6): 303-318.
16. Walter D, Satheesha S, Albrecht P et al. CD133 positive embryonal rhabdomyosarcoma stem-like cell population is enriched in rhabdospheres. PLoS One 2011; 6: e19506.
17. Pressey JG, Haas MC, Pressey CS et al. CD133 marks a myogenically primitive subpopulation in rhabdomyosarcoma cell lines that are relatively chemoresistant but sensitive to mutant HSV. Pediatr Blood Cancer. DOI: 10.1002/pbc24117. Epub ahead of print 2012.
18. Dean M. ABC transporters, drug resistance, and cancer stem cells. J Mammary Gland Biol Neoplasia 2009; 14(1): 3-9.
19. Murase M, Kano M, Tsukahara T et al. Side population cells have the characteristics of cancer stem-like cells/cancer-initiating cells in bone sarcomas. Br J Cancer 2009; 101(8): 1425-1432.
20. Krupkova O Jr, Loja T, Zambo I et al. Nestin expression in human tumors and tumor cell lines. Neoplasma 2010; 57(4): 291-298.
21. Kobayashi M, Sjöberg G, Söderhäll S et al. Pediatric rhabdomyosarcomas express the intermediate filament nestin. Pediatr Res 1998; 43(3): 386-392.
22. Zambo I, Hermanova M, Adamkova Krakorova D et al. Nestin expression in high-grade osteosarcomas and its clinical significance. Oncol Rep 2012; 27(5): 1592-1598.
23. Adhikari AS, Agarwal N, Iwakuma T. Metastatic potential of tumor-initiating cells in solid tumors. Front Biosci 2011; 16: 1927-1938.
24. Wang L, Park P, Zhang H et al. Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99-1 cells based on high aldehyde dehydrogenase activity. Int J Cancer 2011; 128(2): 294-303.
25. Awad O, Yustein JT, Shah P et al. High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-Fli1 inhibition. PLoS One 2010; 5: e13943.
26. Dani N, Olivero M, Mareschi K et al. The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors. J Bone Miner Res 2012; 27(6): 1322-1334.
27. Adhikari AS, Agarwal N, Wood BM et al. CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance. Cancer Res 2010; 70(11): 4602-4612.
28. Zhang M, Song T, Yang L et al. Nestin and CD133: Valuable stem cell-specific markers for determining clinical outcome of glioma patients. J Exp Clin Cancer Res 2008; 27: 85.
29. Dell'Albani P, Pellitteri R, Tricarichi EM et al. Markers of stem cells in gliomas. In: Hayat MA (ed.). Tumors of the Central Nervous System. Vol. 1. Springer 2011: 175-190.